Received Nov 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y005922 | — |
No additional AE; Administrator reported that VARIVAX which was improperly stored was administered. No symptoms reported. Also see AE cases 02890897 and 02890913. No additional AE/no PQC reported. ? Names of vaccines involved (including lot/exp) VARIVAX Y; This spontaneous report was received from an "administrator" (an unspecified reporter) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 15-Oct-2025, the patient was vaccinated with an improperly storage dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Y005922, expiration date: 13-Mar-2026) 0.5 mL (anatomical location and administration route were not reported); diluted with a sterile diluent Solution for injection (Hollister-Stier STERILE DILUENT) (lot #, expiration date, anatomical location and administration route were not reported) administered as prophylaxis. No symptoms or adverse events were reported. It was confirmed that the temperature excursion occurred at 6 Fahrenheit degrees (F) up to 14 (F) for 1 hour and 30 minutes; also, at 14 F up to 46 F (19.9F) for 1 hour. Previous temperature excursions were also reported at 6 F up to 14 F (7.5F) for 1 hour 15 minutes, at 6 F up to 14 F for 30 minutes and finally at 14 F up to 46 F (20.9F) for 30 minutes.
sterile diluent